Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lifco AB in connection with the business acquisition of Aponox Oy
Mandate

Vinge advises Lifco AB in connection with the business acquisition of Aponox Oy

October 06, 2009

Vinge is advising Lifco AB in connection with its subsidiary, KINSHOFER Gmbh’s acquisition of the business operations of the Finnish Aponox Oy via the newly-formed subsidiary, KINSHOFER Aponx Oy. KINSHOFER Gmbh is one of the world’s largest manufacturers of crane and excavator attachments and is a subsidiary of Lifco AB, which is a subsidiary of Carl Bennet AB. Aponox Oy is a Finnish manufacturer of primarily loaders for cranes and excavators using new, revolutionary technology.

Partner Erik Gabrielson is advising Lifco AB in connection with the acquisition.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026